Glenmark Pharmaceuticals has emerged as a short-term bullish pick based on technical chart patterns, with analysts pointing to a solid support base established above ₹2,150.
The stock’s recent price action is described as following a strong trendline, indicating potential for further upward movement in the near term.
This technical signal comes as Indian equity markets have maintained a positive trajectory.
The benchmark Nifty 50 index recently rose 0.44%, while the BSE Sensex added 360.85 points to trade at 77,163.75, reflecting sustained buying interest across the broader market.
The recommendation aligns with a series of daily stock picks released by market research firms, including marketSmith India, which has been highlighting specific equities for short-term trading opportunities.
Investors are advised to monitor the ₹2,150 level as a key support zone; a break below this threshold could invalidate the bullish technical thesis.